AI and omics unlock personalized drugs and RNA therapies for heart disease

AI, omics, and systems biology can now help scientists design targeted drugs for cardiovascular disease pathways once thought “untreatable.”

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup